Author:
Chivukula Mamatha,Bhargava Rohit,Brufsky Adam,Surti Urvashi,Dabbs David J
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference16 articles.
1. Hammock L, Lewis M, Phillips C, et al. Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization. Hum Pathol 2003;34:1043–1047.
2. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology; College of American Pathologists. American Society of Clinical Oncology/College of American Pathologists Guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Path Lab Med 2007;131:18–43.
3. Carlson RW, Moench SJ, Hammond ME, et al. NCCN HER2 testing in breast cancer task force. HER2 testing in breast cancer: NCCN task force report and recommendations. Natl Compr Canc Netw 2006;4 (Suppl 3):S1–S22; quiz S23–S24.
4. Perez EA, Roche PC, Jenkins RB, et al. HER2 Testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization. Mayo Clin Proc 2002;77:148–154.
5. Diaz NM . Laboratory testing of HER-2/neu in breast carcinoma: an evolving strategy to predict response to targeted therapy. Can Control 2001;8:415–418.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献